Navigable Slide Index

1. Introduction
2. Why IBD?
3. Increasing incidence and prevalence of IBD
4. Genetic testing
5. IBD-specific serologic immune markers
6. Video capsule endoscopy
7. Ulcerations in endoscopy
8. CT enterography
9. MR enteroclysis
10. Goals of therapy
11. Therapeutic pyramid
12. Site of oral mesalamine release
13. Anti-TNF “engineered” antibodies
14. Anti-adhesion mechanism of action
15. SONIC: Steroid free CD remission at week 26
16. Clinical response for UC at weeks 8 & 30
17. Update on infliximab: post-op
18. Anti-TNF: update on side effect profile
19. Adverse events with common regimens for CD
20. “Can I stop my medicine?”
21. Newer biologics
22. Other agents under investigation
23. New form of steroid
24. Miscellaneous agents
25. CAM and IBD
26. Probiotics and CD
27. Probiotics and UC
28. Prebiotics and UC
29. Another alternative agent
30. Herbal supplements
31. Summary points

Topics Covered

• Increasing incidence and prevalence of IBD
• Genetic testing & immune markers
• Video capsule endoscopy & imaging
• Therapy
• Combination therapy
• Newer biologics
• Complementary & alternative medicine

Links

Series:

• Gastroenterology and Hepatology

Categories:

• Diseases, Disorders, & Treatments
• Immunology
• Metabolism & Nutrition

Therapeutic Areas:

• Immunology & Inflammation

Talk Citation

Kane, S. (2011), "Inflammatory bowel disease: what the internist should know", in The Biomedical & Life Sciences Collection, Henry Stewart Talks Ltd, London (online at https://hstalks.com/bs/1907/)

Talk Information

• Published on January 5, 2011
• Updated on November 30, 2016